PRV-002
PRV-002-AU-01
Phase 1 small_molecule completed
Quick answer
PRV-002 for Traumatic Brain Injury (TBI) is a Phase 1 program (small_molecule) at Odyssey Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Odyssey Therapeutics
- Indication
- Traumatic Brain Injury (TBI)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed